CytomX Therapeutics (CTMX) Times Interest Earned (2016 - 2017)
Historic Times Interest Earned for CytomX Therapeutics (CTMX) over the last 4 years, with Q1 2017 value amounting to -$41.82.
- CytomX Therapeutics' Times Interest Earned rose 878.21% to -$41.82 in Q1 2017 from the same period last year, while for Dec 2017 it was -$224.56, marking a year-over-year decrease of 53652.35%. This contributed to the annual value of -$35.28 for FY2016, which is 8402.85% down from last year.
- CytomX Therapeutics' Times Interest Earned amounted to -$41.82 in Q1 2017, which was up 878.21% from -$36.58 recorded in Q4 2016.
- CytomX Therapeutics' Times Interest Earned's 5-year high stood at -$13.58 during Q2 2015, with a 5-year trough of -$45.84 in Q1 2016.
- For the 4-year period, CytomX Therapeutics' Times Interest Earned averaged around -$30.84, with its median value being -$30.66 (2016).
- In the last 5 years, CytomX Therapeutics' Times Interest Earned soared by 4698.86% in 2015 and then tumbled by 12573.52% in 2016.
- CytomX Therapeutics' Times Interest Earned (Quarter) stood at -$42.74 in 2014, then rose by 28.3% to -$30.65 in 2015, then dropped by 19.35% to -$36.58 in 2016, then fell by 14.31% to -$41.82 in 2017.
- Its Times Interest Earned stands at -$41.82 for Q1 2017, versus -$36.58 for Q4 2016 and -$30.95 for Q3 2016.